NCT02903160 2024-02-07Prostate Cancer Intensive, Non-Cross Reactive Therapy (PRINT) for Castration Resistant Prostate Cancer (CRPC)Icahn School of Medicine at Mount SinaiPhase 2 Completed40 enrolled 18 charts
NCT00337155 2023-11-02BAY88-8223, Dose Finding Study in Patients With HRPCBayerPhase 2 Completed122 enrolled
NCT00459654 2014-06-25A Placebo-controlled Phase II Study of Bone-targeted Radium-223 in Symptomatic Hormone-refractory Prostate CancerBayerPhase 2 Completed64 enrolled